Scribe Therapeutics cofounder and CEO Benjamin Oakes, PhD, joins a16z Bio + Health founding general partner Vijay Pande.
In this episode, Benjamin traces his journey from PhD student to pioneering CEO in genome editing. Benjamin discusses his early exposure to CRISPR technologies, his hands-on experience of transforming these bacterial immune systems into "genome editing scalpels," and the founding of Scribe. The conversation sheds light on the challenges of engineering these molecules, as well as the potential for life-changing therapeutics.
Past, Present, and Future of AI with Vijay Pande
Fireside Chat with Sean Duffy
Introducing: Raising Health
Generalist Medical AI with Pranav Rajpurkar
Gate Unveiling with Jordi Mata-Fink
How to Build an AI-Native Health Plan with Mario Schlosser
Bridging AI, Ethics, and Consumer Trust with Miriam Vogel
Clinical Copilots: Augmenting Human Care with Suchi Saria
The Worlds She Sees with Fei-Fei Li
Supercharging Discovery with Evan Feinberg
Evolving Biotechnologies with Olga Troyanskaya
CMO vs. CPO with Peter Shalek and Reena Pande
Interpretability and the AI "Clear Box" with Surya Ganguli
AI Revolution with Daphne Koller
When Quantity Becomes Quality with Aviv Regev
Navigating the Future of AI with Andrew Ng
Unleashing CAR T with Carl June
Becoming a Partnership Pioneer with Dan Nomura
Wartime and Peacetime: Being a Leader with Ben Horowitz
Medical Education and AI with Lloyd B. Minor
Create your
podcast in
minutes
It is Free